Robert P. Aspbury
President of Model Informed Discovery & Drug DevelopmentDr. Robert P. Aspbury, PhD, also known as Rob, is President of Model Informed Discovery & Drug Development at Certara, Inc. since 2026 and also served as President of Certara Predictive Technologies from April 2025 to 2026 and was President of Certara Scientific Software since 2023 until April 2025 and was its President of Simcyp Division since January 2020 until 2023. Prior to this appointment, he served as Simcyp’s Chief Operating Officer from April 2019 to December 2019. Dr. Aspbury served as Chief Operating Officer and Member of Simcyp Scientific Advisory Board at Certara, L.P. since April 2019. Dr. Aspbury had extensive commercial and scientific leadership experience with Covance. Dr. Aspbury was appointed Global Finance Director for Covance’s Clinical Pharmacology Services Division in 2003 and was rapidly promoted within the division to Managing Director, then Vice President, Europe and later Vice President and General Manager, Global. His most recent appointment was Vice President of Strategic Solutions, Biosimilars for Covance Inc from September 2016 to March 2019 and as Vice President and General Manager, Global Clinical Pharmacology from November 2011 to August 2016. Dr. Aspbury earned a doctorate in biochemistry from the University of Liverpool in 1995. He is also a chartered accountant.
Positions
- Company NameCertara, Inc.Stock CodeCERTPositionPresident of Model Informed Discovery & Drug DevelopmentColleagues
- JEJames E. CashmanIndependent Chairman of the Board
- LELeif E. PedersenSenior Advisor
- AKAdrian K. McKemeyPresident of Development Strategy & Evidence
- JRJon ResnickCEO & Director
- JPJulien PerrierPresident & Chief Commercial Officer
- MMMatthew M. WalshIndependent Director
- NKNancy KilleferIndependent Director
- EBEran BroshyIndependent Director
